Brief: Aroa Biosurgery Says Prelim Unaudited FY22 Product Revenue Of About NZ$39.2 Mln
26/04/2022 02:56
April 26 (Reuters) - Aroa Biosurgery Ltd ARX.AX :
* PRELIMINARY UNAUDITED FY22 FULL YEAR PRODUCT REVENUE OF
ABOUT
NZ$39.2 MILLION
* FY22 PRELIMINARY UNAUDITED TOTAL REVENUE ABOUT NZ$39.7
MILLION,
UP ABOUT 78%
Source text for Eikon: ID:nASX8lf5dH
Further company coverage: ARX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million